Top Section/Ad
Top Section/Ad
Most recent
Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
More articles/Ad
More articles/Ad
More articles
-
Swiss pharma firm's stock rose after it announced dilutive block trade -
Global agencies battling to solve Africa’s glaringly low Covid vaccination rates face indifference, obstinacy and ‘me first’ attitudes in developed world.
-
The world economy is recovering strongly from the pandemic, but low and middle income countries are being left behind. They are looking to the North for vaccines, leniency on debt and fresh development financing
-
US medtech firm raises €5.25bn for acquisition
-
Swiss hospitals are increasingly looking to the local bond market to fund expansion
-
Deutsche Bank is among the firms making a concerted effort to bulk up their capabilities in the healthcare sector, with two managing directors set to join the firm in the coming months.
